ViewRay (VRAYQ) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock VRAYQ vs. AFIB, BRSH, SDCCQ, GMVDF, AHPI, NMRD, MOTS, UTRS, VIVE, and DRTSWShould you be buying ViewRay stock or one of its competitors? The main competitors of ViewRay include Acutus Medical (AFIB), Bruush Oral Care (BRSH), SmileDirectClub (SDCCQ), G Medical Innovations (GMVDF), Allied Healthcare Products (AHPI), Nemaura Medical (NMRD), Motus GI (MOTS), Minerva Surgical (UTRS), Viveve Medical (VIVE), and Alpha Tau Medical (DRTSW). These companies are all part of the "medical equipment" industry. ViewRay vs. Its Competitors Acutus Medical Bruush Oral Care SmileDirectClub G Medical Innovations Allied Healthcare Products Nemaura Medical Motus GI Minerva Surgical Viveve Medical Alpha Tau Medical ViewRay (NASDAQ:VRAYQ) and Acutus Medical (NASDAQ:AFIB) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, earnings, institutional ownership, profitability, valuation and risk. Is VRAYQ or AFIB more profitable? ViewRay has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. ViewRay's return on equity of 0.00% beat Acutus Medical's return on equity.Company Net Margins Return on Equity Return on Assets ViewRayN/A N/A N/A Acutus Medical -272.74%-311.64%-11.57% Which has more risk & volatility, VRAYQ or AFIB? ViewRay has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500. Comparatively, Acutus Medical has a beta of -0.34, suggesting that its stock price is 134% less volatile than the S&P 500. Do institutionals & insiders have more ownership in VRAYQ or AFIB? 15.5% of ViewRay shares are held by institutional investors. Comparatively, 56.9% of Acutus Medical shares are held by institutional investors. 2.5% of ViewRay shares are held by company insiders. Comparatively, 5.2% of Acutus Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media refer more to VRAYQ or AFIB? In the previous week, Acutus Medical had 2 more articles in the media than ViewRay. MarketBeat recorded 2 mentions for Acutus Medical and 0 mentions for ViewRay. Acutus Medical's average media sentiment score of 0.12 beat ViewRay's score of 0.00 indicating that Acutus Medical is being referred to more favorably in the news media. Company Overall Sentiment ViewRay Neutral Acutus Medical Neutral Which has higher earnings and valuation, VRAYQ or AFIB? Acutus Medical has lower revenue, but higher earnings than ViewRay. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViewRay$102.21M0.00-$107.33MN/AN/AAcutus Medical$7.16M0.01-$81.66MN/AN/A SummaryViewRay and Acutus Medical tied by winning 5 of the 10 factors compared between the two stocks. Get ViewRay News Delivered to You Automatically Sign up to receive the latest news and ratings for VRAYQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VRAYQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VRAYQ vs. The Competition Export to ExcelMetricViewRayElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$18K$32.11M$5.54B$9.05BDividend YieldN/AN/A5.24%4.02%P/E RatioN/A3.5127.4320.22Price / SalesN/A194.56416.87118.64Price / CashN/A41.3636.8958.07Price / BookN/A2.228.035.67Net Income-$107.33M-$25.54M$3.18B$249.13M ViewRay Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRAYQViewRayN/AN/AN/AN/A$18K$102.21M0.00300Gap DownAFIBAcutus MedicalN/A$0.00flatN/AN/A$60K$7.16M0.00340Gap UpBRSHBruush Oral CareN/AN/AN/AN/A$44K$2.92M0.0011Gap DownSDCCQSmileDirectClubN/A$0.00+∞N/A-95.0%$40K$470.74M0.002,700Gap UpGMVDFG Medical InnovationsN/AN/AN/AN/A$26K$4.42M0.0072AHPIAllied Healthcare ProductsN/AN/AN/AN/A$16K$27.05M0.00150Gap UpNMRDNemaura Medical1.0319 of 5 stars$0.00flatN/AN/A$4K$3.02K0.0040MOTSMotus GI0.075 of 5 stars$0.00flatN/AN/A$2K$319K0.0030UTRSMinerva SurgicalN/AN/AN/AN/A$1K$51.69M0.00160VIVEViveve MedicalN/A$0.00flatN/AN/A$1K$6.83M0.0070High Trading VolumeDRTSWAlpha Tau MedicalN/A$0.24-3.1%N/A+5.5%$0.00N/A0.0080News CoverageGap Down Related Companies and Tools Related Companies Acutus Medical Alternatives Bruush Oral Care Alternatives SmileDirectClub Alternatives G Medical Innovations Alternatives Allied Healthcare Products Alternatives Nemaura Medical Alternatives Motus GI Alternatives Minerva Surgical Alternatives Viveve Medical Alternatives Alpha Tau Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VRAYQ) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ViewRay, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ViewRay With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VRAYQ Stock Alerts